Skip to main content

Animations

MJFF Publications

7721 - 7730 of 8819 Results
Title
Year
  • Year
  • 2023
  • 2023
  • 2023
  • 2023
  • 2025
  • 2024
  • 2024
  • 2025
  • 2024
  • 2024
  • Summary Details
    OPEN
    Title: Potential Protective Link Between Type I Diabetes and Parkinson's Disease Risk and Progression
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.29424
    Citation Count: 11
  • Summary Details
    OPEN
    Title: An ankyrin repeat chaperone targets toxic oligomers during amyloidogenesis
    Journal Name: Protein Science
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/pro.4728
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Neurofilament light chain in spinal fluid and plasma in multiple system atrophy: a prospective, longitudinal biomarker study
    Journal Name: Clinical Autonomic Research
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s10286-023-00974-6
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Pharmacological Inhibition of PTEN Rescues Dopaminergic Neurons by Attenuating Apoptotic and Neuroinflammatory Signaling Events
    Journal Name: Journal of Neuroimmune Pharmacology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s11481-023-10077-8
    Citation Count: 5
  • Summary Details
    RESTRICTED
    Title: Large-scale plasma proteomic profiling unveils diagnostic biomarkers and pathways for Alzheimer’s disease
    Journal Name: Nature Aging
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1038/s43587-025-00872-8
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Dopamine D1–D5 Receptors in Brain Nuclei: Implications for Health and Disease
    Journal Name: Receptors
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/receptors3020009
    Citation Count: 28
  • Summary Details
    OPEN
    Title: Effect of the mGlu 2 positive allosteric modulator biphenyl‐indanone A as a monotherapy and as adjunct to a low dose of L‐DOPA in the MPTP‐lesioned marmoset
    Journal Name: European Journal of Neuroscience
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1111/ejn.16454
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Characterizing the expression profile of 3R tau pathology in Pick’s disease
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1126/sciadv.adt6105
    Citation Count: 1
  • Summary Details
    OPEN
    Title: P2RX7, an adaptive immune response gene, is associated with Parkinson's disease risk and age at onset
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1177/1877718x241296015
    Citation Count: 0
  • Summary Details
    OPEN
    Title: New insights from a Malaysian real-world deep brain stimulation cohort
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1177/1877718x241297715
    Citation Count: 0
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.